Physician

Charles S. Lin, M.D.

According to 2025 Medicare claims, Charles Lin, M.D. (NPI: 1326042185) practices cardiac electrophysiology in the Bowling Green, KY market, with the plurality of this provider's patient population coming from Warren, KY. This provider's primary affiliated billing organization is GRAVES GILBERT CLINIC PLLC (NPI: 1114948288; TIN: 610700826) and primary practice location at 42101-1759. Lin is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and GGC ValueCare LLC (ACO ID: A5611), participating under the MSSP model.

Lin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 697 traditional Medicare patients, billed 9,575 HCPCS/CPT codes, and received $304,560 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 11,628 prescription claims across 836 beneficiaries totaling $2,847,433 in drug costs, led by Eliquis (Apixaban). DME data shows 35 claims. Open Payments data shows 40 records totaling $720. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $518,620 to $304,560. In contrast, Part D prescription costs have moved sharply higher in recent years, from $722,293 to $2,847,433. For DME billing, this smaller-volume category fell sharply in recent years, from $24,034 to $3,312.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,133	9,412	$518,620
2016	1,148	8,771	$468,219
2017	1,071	8,880	$462,066
2018	1,110	8,669	$452,154
2019	1,076	8,385	$446,542
2020	884	5,861	$317,067
2021	799	6,931	$403,919
2022	779	6,772	$346,119
2023	769	10,153	$374,771
2024	697	9,575	$304,560

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	713	8,012	$722,293
2016	720	6,809	$709,524
2017	744	9,440	$1,106,039
2018	742	8,592	$1,054,912
2019	766	8,251	$1,122,935
2020	758	9,263	$1,487,369
2021	748	9,489	$1,866,988
2022	774	10,255	$2,269,068
2023	776	10,816	$2,631,569
2024	836	11,628	$2,847,433

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$23,875
2016	N/R	13	$27,829
2017	N/R	74	$64,908
2018	N/R	50	$725
2019	N/R	71	$735
2020	N/R	169	$12,598
2021	N/R	65	$685
2022	N/R	41	$2,742
2023	N/R	48	$3,355
2024	N/R	35	$2,835

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	312	317	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	603	1,523	$85
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	157	167	$50
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	132	164	$10
82550	Creatine kinase (cardiac enzyme) level, total	89	91	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	801	36,831	$691,017
Entresto	Sacubitril/Valsartan	654	28,620	$609,606
Farxiga	Dapagliflozin Propanediol	625	26,392	$480,863
Jardiance	Empagliflozin	187	8,101	$155,348
Brilinta	Ticagrelor	192	9,630	$133,714

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	22	$2,297
E1392	Portable oxygen concentrator, rental	Y	N/R	13	$539

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$720	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles S. Lin, M.D.?

Tedicare shows public-source Medicare data for Charles S. Lin, M.D. (NPI 1326042185), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles S. Lin, M.D. have ACO affiliation data?

Charles S. Lin, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and GGC ValueCare LLC (MSSP, ACO ID A5611).

What billing organization is linked to Charles S. Lin, M.D.?

Charles S. Lin, M.D. is linked to GRAVES GILBERT CLINIC PLLC (billing NPI 1114948288) in the available physician profile data.

Does Charles S. Lin, M.D. have Open Payments data?

Charles S. Lin, M.D. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.